KALA BIO, INC. Common Stock, Value, Issued
KALA BIO, INC. (KALA) had Common Stock, Value, Issued of $20.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-19
- 2026-06-30: Common Stock, Value, Issued $20.00K.
- 2026-03-31: Common Stock, Value, Issued $19.00K.
- 2025-12-31: Common Stock, Value, Issued $1.00K; Common Stock, Value, Issued as first filed $28.00K.
- 2025-09-30: Common Stock, Value, Issued $7.00K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $20.00K 10-Q · filed 2026-08-19 | |
| 2026-03-31 | $19.00K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $1.00K 10-Q · filed 2026-08-19 | $28.00K 10-K · filed 2026-04-15 |
| 2025-09-30 | $7.00K 10-Q · filed 2025-11-19 | |
| 2025-06-30 | $7.00K 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $6.00K 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $6.00K 10-K · filed 2026-04-15 | |
| 2024-09-30 | $5.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $5.00K 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $3.00K 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $3.00K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $3.00K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $3.00K 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $2.00K 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $2.00K 10-K · filed 2024-03-29 | |
| 2022-09-30 | $1.00K 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $73.00K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $73.00K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $1.00K 10-K · filed 2023-03-03 | $66.00K 10-K · filed 2022-03-29 |
| 2021-09-30 | $65.00K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $65.00K 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $64.00K 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $59.00K 10-K · filed 2022-03-29 | |
| 2020-09-30 | $56.00K 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $56.00K 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $55.00K 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $36.00K 10-K · filed 2021-02-25 | |
| 2019-09-30 | $35.00K 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $34.00K 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $34.00K 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $34.00K 10-K · filed 2020-02-12 | |
| 2018-09-30 | $25.00K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $25.00K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $25.00K 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $25.00K 10-K · filed 2019-03-12 | |
| 2017-09-30 | $24.00K 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $1.00K 10-Q · filed 2017-08-31 | |
| 2016-12-31 | $1.00K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |